Tags:ActiveBusinessDevelopmentDrugEngineeringManagementMarketPharmacyProductSpecialty
Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and management.
Location: United Kingdom, England, Oxford
Total raised: $46.820436M

Investors 3

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
24.05.2012Series B$26.810071...-finsmes.co...
07.07.2011-$18.202895...-finsmes.co...
-Grant$1.80747M-entreprene...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
24.05.2012Prosonix R...Prosonix, a Oxford, UK-based s...funding U...-finsmes.co...
07.07.2011Prosonix R...Prosonix Ltd., an Oxford, UK-b...funding U...-finsmes.co...
-Prosonix R...The award will support a resea...--entreprene...